Literature DB >> 21498618

Molecular consequences of BEST1 gene mutations in canine multifocal retinopathy predict functional implications for human bestrophinopathies.

Karina E Guziewicz1, Julianna Slavik, Sarah J P Lindauer, Gustavo D Aguirre, Barbara Zangerl.   

Abstract

PURPOSE: Bestrophin-1 gene (BEST1) mutations are responsible for a broad spectrum of human retinal phenotypes, jointly called bestrophinopathies. Canine multifocal retinopathy (cmr), caused by mutations in the dog gene ortholog, shares numerous phenotypic features with human BEST1-associated disorders. The purpose of this study was the assessment of molecular consequences and pathogenic outcomes of the cmr1 (C(73)T/R(25)X) premature termination and the cmr2 (G(482)A/G(161)D) missense mutation of the canine model compared with the C(87)G/Y(29)X mutation observed in human patients.
METHODS: Dogs carrying the BEST1 mutation were introduced into a breeding colony and used to produce either carrier or affected offspring. Eyes were collected immediately after euthanatization at the disease-relevant ages and were harvested for expression studies. In parallel, an in vitro cell culture model system was developed and compared with in vivo
RESULTS: The results demonstrate that cmr1 and human C(87)G-mutated transcripts bypass the nonsense-mediated mRNA decay machinery, suggesting the AUG proximity effect as an underlying transcriptional mechanism. The truncated protein, however, is not detectable in either species. The in vitro model accurately recapitulates transcriptional and translational expression events observed in vivo and, thus, implies loss of bestrophin-1 function in cmr1-dogs and Y(29)X-affected patients. Immunofluorescence microscopy of cmr2 mutant showed mislocalization of the protein.
CONCLUSIONS: Molecular evaluation of cmr mutations in vivo and in vitro constitutes the next step toward elucidating genotype-phenotype interactions concerning human bestrophinopathies and emphasizes the importance of the canine models for studying the complexity of the BEST1 disease mechanism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21498618      PMCID: PMC3175949          DOI: 10.1167/iovs.10-6385

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  46 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons.

Authors:  Laure Perrin-Vidoz; Olga M Sinilnikova; Dominique Stoppa-Lyonnet; Gilbert M Lenoir; Sylvie Mazoyer
Journal:  Hum Mol Genet       Date:  2002-11-01       Impact factor: 6.150

3.  Gene therapy restores vision in a canine model of childhood blindness.

Authors:  G M Acland; G D Aguirre; J Ray; Q Zhang; T S Aleman; A V Cideciyan; S E Pearce-Kelling; V Anand; Y Zeng; A M Maguire; S G Jacobson; W W Hauswirth; J Bennett
Journal:  Nat Genet       Date:  2001-05       Impact factor: 38.330

4.  The vitelliform macular dystrophy protein defines a new family of chloride channels.

Authors:  Hui Sun; Takashi Tsunenari; King-Wai Yau; Jeremy Nathans
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

5.  Assessment of mutations in the Best macular dystrophy (VMD2) gene in patients with adult-onset foveomacular vitelliform dystrophy, age-related maculopathy, and bull's-eye maculopathy.

Authors:  J M Seddon; M A Afshari; S Sharma; P S Bernstein; S Chong; A Hutchinson; K Petrukhin; R Allikmets
Journal:  Ophthalmology       Date:  2001-11       Impact factor: 12.079

6.  Expression of bestrophin-1, the product of the VMD2 gene, modulates voltage-dependent Ca2+ channels in retinal pigment epithelial cells.

Authors:  Rita Rosenthal; Benjamin Bakall; Tyson Kinnick; Neal Peachey; Sönke Wimmers; Claes Wadelius; Alan Marmorstein; Olaf Strauss
Journal:  FASEB J       Date:  2005-11-10       Impact factor: 5.191

7.  Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration.

Authors:  F Krämer; K White; D Pauleikhoff; A Gehrig; L Passmore; A Rivera; G Rudolph; U Kellner; M Andrassi; B Lorenz; K Rohrschneider; A Blankenagel; B Jurklies; H Schilling; F Schütt; F G Holz; B H Weber
Journal:  Eur J Hum Genet       Date:  2000-04       Impact factor: 4.246

8.  Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa.

Authors:  Weng Tao; Rong Wen; Moses B Goddard; Sandy D Sherman; Pam J O'Rourke; Paul F Stabila; William J Bell; Brenda J Dean; Konrad A Kauper; Veronica A Budz; William G Tsiaras; Gregory M Acland; Sue Pearce-Kelling; Alan M Laties; Gustavo D Aguirre
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-10       Impact factor: 4.799

9.  In vivo micropathology of Best macular dystrophy with optical coherence tomography.

Authors:  Michael J Pianta; Tomas S Aleman; Artur V Cideciyan; Janet S Sunness; Yuanyuan Li; Betsy A Campochiaro; Peter A Campochiaro; Donald J Zack; Edwin M Stone; Samuel G Jacobson
Journal:  Exp Eye Res       Date:  2003-02       Impact factor: 3.467

10.  Structure-function analysis of the bestrophin family of anion channels.

Authors:  Takashi Tsunenari; Hui Sun; John Williams; Hugh Cahill; Philip Smallwood; King-Wai Yau; Jeremy Nathans
Journal:  J Biol Chem       Date:  2003-08-07       Impact factor: 5.157

View more
  13 in total

Review 1.  Bestrophin 1 and retinal disease.

Authors:  Adiv A Johnson; Karina E Guziewicz; C Justin Lee; Ravi C Kalathur; Jose S Pulido; Lihua Y Marmorstein; Alan D Marmorstein
Journal:  Prog Retin Eye Res       Date:  2017-01-30       Impact factor: 21.198

2.  Modeling the structural consequences of BEST1 missense mutations.

Authors:  Karina E Guziewicz; Gustavo D Aguirre; Barbara Zangerl
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

3.  Retinal structure in young patients aged 10 years or less with Best vitelliform macular dystrophy.

Authors:  Patrik Schatz; Dror Sharon; Sermed Al-Hamdani; Sten Andréasson; Michael Larsen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-05       Impact factor: 3.117

4.  Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis.

Authors:  Rebecca E H Whiting; Jacqueline W Pearce; Leilani J Castaner; Cheryl A Jensen; Rebecca J Katz; Douglas H Gilliam; Martin L Katz
Journal:  Exp Eye Res       Date:  2015-02-16       Impact factor: 3.467

Review 5.  Bestrophinopathy: An RPE-photoreceptor interface disease.

Authors:  Karina E Guziewicz; Divya Sinha; Néstor M Gómez; Kathryn Zorych; Emily V Dutrow; Anuradha Dhingra; Robert F Mullins; Edwin M Stone; David M Gamm; Kathleen Boesze-Battaglia; Gustavo D Aguirre
Journal:  Prog Retin Eye Res       Date:  2017-01-19       Impact factor: 21.198

6.  Optic nerve colobomas associated with unilateral focal serous retinal detachment in a dog - In-vivo imaging and outcome following laser retinopexy.

Authors:  Valerie L Dufour; Julie A Cohen; Dolores M Holle; Gustavo D Aguirre
Journal:  Vet Ophthalmol       Date:  2021-10-28       Impact factor: 1.444

7.  Effects of alternative splicing on the function of bestrophin-1 calcium-activated chloride channels.

Authors:  Yu-Hung Kuo; Iskandar F Abdullaev; María C Hyzinski-García; Alexander A Mongin
Journal:  Biochem J       Date:  2014-03-15       Impact factor: 3.857

8.  Recombinant AAV-mediated BEST1 transfer to the retinal pigment epithelium: analysis of serotype-dependent retinal effects.

Authors:  Karina E Guziewicz; Barbara Zangerl; András M Komáromy; Simone Iwabe; Vincent A Chiodo; Sanford L Boye; William W Hauswirth; William A Beltran; Gustavo D Aguirre
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

9.  A novel form of progressive retinal atrophy in Swedish vallhund dogs.

Authors:  Ann E Cooper; Saija Ahonen; Jessica S Rowlan; Alison Duncan; Eija H Seppälä; Päivi Vanhapelto; Hannes Lohi; András M Komáromy
Journal:  PLoS One       Date:  2014-09-08       Impact factor: 3.240

10.  Mutant Best1 Expression and Impaired Phagocytosis in an iPSC Model of Autosomal Recessive Bestrophinopathy.

Authors:  Alan D Marmorstein; Adiv A Johnson; Lori A Bachman; Cynthia Andrews-Pfannkoch; Travis Knudsen; Benjamin J Gilles; Matthew Hill; Jarel K Gandhi; Lihua Y Marmorstein; Jose S Pulido
Journal:  Sci Rep       Date:  2018-03-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.